SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MedImmune
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
416 47 0 MEDI
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
391MedImmune to sell CytoGam to ZLB Behring Briefing.com - November 08, 2006 5:15 Psjemmeri-11/8/2006
390Season Near, Flu Fighter Is Confident [NYT] Saturday Interview By ELIZABETH OLSDoc Bones-11/6/2006
389Numax(R) Achieves Primary Endpoint In Preliminary Analysis of Data From Comparatnigel bates-11/6/2006
388Higher Antibody Responses Observed in Young Children Receiving MedImmune`s Invessjemmeri-10/13/2006
387baltimoresun.com From the Baltimore Sun Bio gambler raises its bets MedImmuneEdscharp-10/3/2006
386MedImmune and Infinity Pharmaceuticals Announce Cancer Drug Development and WorlMike McFarland-8/29/2006
385MedImmune Files Investigational New Drug Application for MT103 August 21, 2006sjemmeri-8/21/2006
384MEDI seeking approval for refrigerator stable Flumist (CAIV-T) in kids age 12 motechnetium-8/1/2006
383Weak Showing at MedImmune By TSC Staff 7/20/2006 7:37 AM EDT MedImmune (Doc Bones-7/20/2006
382Way to mass produce key bird flu drug revealed 11:52 04 May 2006 NewScientist.Doc Bones-5/7/2006
381MedImmune Awarded $170 Million, Five-Year Contract From U.S. Health and Human Senigel bates-5/4/2006
380MedImmune Begins Dosing of Lupus Patients in Phase 1 Clinical Trial Thursday Aprnigel bates-4/13/2006
379Additional Preclinical and Clinical Data Indicate Abegrin(TM) May Offer Three-Prnigel bates-4/10/2006
378Medimmune Math Adds Up to Higher Value Justin Ferayorni The company's labeDoc Bones-3/8/2006
377Pre market mover CHICAGO, Dec 12 (Reuters) - MedImmune Inc.(MEDI.O: Quote, Proftom pope-12/12/2005
376MedImmune Expands Oncology Pipeline with Increased Focus on Eph Proteins as Potenigel bates-12/8/2005
375MedImmune Licenses Xencor's XmAb(TM) Technology to Create Antibody Therapeutnigel bates-12/7/2005
374MedImmune Licenses BioWa, Inc.'s POTELLIGENT(TM) Technology for Use in Antibnigel bates-12/7/2005
373Flu Vaccine Causes Only a Few Reports Of Adverse Effects ASSOCIATED PRESS DecemDoc Bones-12/7/2005
372I own some Novartis so I was interested in the Chiron piece. This, from Forbes,tom pope-9/24/2005
371Signals on the current state of the flu vacine business: signalsmag.com Cheerstuck-9/24/2005
370Flu Shot Gets New Formulation By JENNIFER CORBETT DOOREN DOW JONES NEWSWIRES SDoc Bones-9/20/2005
369MedImmune to Acquire Cellective Therapeutics, Inc. 14 September 2005, 08:30am ETFiloF-9/14/2005
368MedImmune Amends U.S. Co-Promotion Agreement for Synagis(R) With Abbott GAITHERnigel bates-9/1/2005
367MedImmune Licenses Worldwide Rights for Anti-Staphylococcal Antibody Program Fronigel bates-9/1/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News